COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,024 Articles (22,627 medRxiv, 8,397 bioRxiv)

Most recent first Previous |  Page 1944: Articles 19431-19440  | Next

A recombinant fragment of Human surfactant protein D binds Spike protein and inhibits infectivity and replication of SARS-CoV-2 in clinical samples
Madan, T., Biswas, B., Varghese, P., Subedi, R., Pandit, H., Idicula-Thomas, S., Kundu, I., Rooge, S. B., Aggarwal, R., Tripathi, D., Kaur, S., Gupta, E., Gupta, S., Kishore, U.
10.1101/2020.12.18.423415 — Posted: 2020-12-18
International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study
Weber, G. M., Hong, C., Palmer, N. P., Avillach, P., Murphy, S. N., Gutierrez-Sacristan, A., Xia, Z., Serret-Larmande, A., Neuraz, A., Omenn, G. S., Visweswaran, S., Klann, J. G., South, A. M., Loh, N. H. W., Cannataro, M., Beaulieu-Jones, B. K., Bellazzi, R., Agapito, G., Alessiani, M., Aronow, B. J., Bell, D. S., Bellasi, A., Benoit, V., Beraghi, M., Boeker, M., Booth, J., Bosari, S., Bourgeois, F. T., Brown, N. W., Chiovato, L., Chiudinelli, L., Dagliati, A., Devkota, B., Follett, R. W., Ganslandt, T., Garcia Barrio, N., Gradinger, T., Griffier, R., Hanauer, D. A., Holmes, J. H., Horki, P., Huling, K. M., Issitt, R. W., Jouhet, V., Keller, M. S., Kraska, D., Liu, M., Luo, Y., Malovini, A., Mandl, K. D., Mao, C., Maram, A., Maulhardt, T., Mauro, B., Milano, M., Moore, J. H., Morris, J. S., Morris, M., Mowery, D. L., Naughton, T. P., Ngiam, K. Y., Norman, J. B., Patel, L. P., Pedrera Jimenez, M., Schriver, E. R., Scudeller, L., Sebire, N. J., Serrano Balazote, P., Spiridou, A., Tan, A. L., Tan, B. W. L., Tibollo, V., Torti, C., Trecarichi, E. M., Trecarichi, M., Vitacca, M., Zambelli, A., Zucco, C., Consortium for Clinical Characterization of COVID-19 by EHR, , Kohane, I. S., Cai, T., Brat, G. A.
10.1101/2020.12.16.20247684 — Posted: 2020-12-18
No evidence of association between schools and SARS-CoV-2 second wave in Italy.
Gandini, S., Rainisio, M., Iannuzzo, M. L., Bellerba, F., Cecconi, F., Scorrano, L.
10.1101/2020.12.16.20248134 — Posted: 2020-12-18 Discussion: Onsite | Offsite
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Richard, A., Wisniak, A., Perez-Saez, J., Garrison-Desany, H., Petrovic, D., Piumatti, G., Baysson, H., Picazio, A., Pennacchio, F., De Ridder, D., Chappuis, F., Vuilleumier, N., Low, N., Hurst, S., Eckerle, I., Flahault, A., Kaiser, L., Azman, A. S., Guessous, I., Stringhini, S., SEROCOV-POP study group
10.1101/2020.12.16.20248180 — Posted: 2020-12-18
The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention
Thaker, J.
10.1101/2020.12.16.20248139 — Posted: 2020-12-18
Household bubbles and COVID-19 transmission: insights from percolation theory
Danon, L., Brooks-Pollock, E., Lacasa, L.
10.1101/2020.12.16.20248311 — Posted: 2020-12-18
Large-Scale Measurement of Aggregate Human Colocation Patterns for Epidemiological Modeling
Iyer, S., Karrer, B., Citron, D. T., Kooti, F., Maas, P., Wang, Z., Giraudy, E., Dow, P. A., Pompe, A.
10.1101/2020.12.16.20248272 — Posted: 2020-12-18
COVID19 is a seasonal climate-driven disease across both hemispheres
Fontal, A., Bouma, M. J., San Jose, A., Pascual, M., Rodo, X.
10.1101/2020.12.16.20248310 — Posted: 2020-12-18
Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China
Bushman, M., Worby, C. J., Chang, H.-H., Kraemer, M. U. G., Hanage, W. P.
10.1101/2020.12.16.20214106 — Posted: 2020-12-18
Clinical validation of a point-of-care antibody test for COVID-19
Patel, M., Lakhotia, Y., Shah, S., Suthar, N., Kola, S., Rangarajan, R.
10.1101/2020.12.16.20248303 — Posted: 2020-12-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).